Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at NASPGHAN Annual Meeting

November 13, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today provided a recap of the November 8, 2025 presentation at the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting describing the initial groundbreaking results of an independent investigator-initiated trial (IIT) of crofelemer in the UAE for treatment of pediatric intestinal failure, which includes...

Read more

Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy

November 13, 2025 8:35 AM

Entero Therapeutics, Inc. (NASDAQ:ENTO) ("Entero" or the "Company") today announced that its wholly owned subsidiary, Grid AI, is finalizing the establishment of a U.S.-based leadership team composed of highly accomplished executives from the energy, power, and technology sectors. This marks a significant step in Grid AI's expansion into the rapidly growing U.S. market for AI-ready digital infrastructure and orchestration technology.Entero...

Read more

National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

November 13, 2025 8:30 AM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced that Reliefacyn® Advanced Itch-Burn-Rash-Pain Relief Hydrogel has earned the National Rosacea Society (NRS) Seal of...

Read more

Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)

November 13, 2025 8:30 AM

Tivic Health Systems, Inc. (Nasdaq:TIVC), a diversified immunotherapeutics company, announced today it has optimized key device and treatment parameters including frequency, amplitude, electrode positioning, and duration of stimulation as a result of its collaborative study with The Feinstein Institutes for Medical Research at Northwell Health.Physiological measurements taken before, during, and after ncVNS treatment found the...

Read more

Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study

November 13, 2025 8:22 AM

Protagenic Therapeutics Inc. (NASDAQ:PTIX), a biopharmaceutical company developing novel therapeutics for stress-related neuropsychiatric and neurodegenerative disorders, today announced the successful completion of enrollment and dosing in its Multiple Ascending Dose (MAD) Phase 1 study evaluating its lead compound, known as PT00114. The study, conducted in healthy volunteers, was designed to assess the safety and tolerability profile of...

Read more

Curiteva Proudly Announces the Publication of a Peer-Reviewed Study in the Journal of Biomaterials (JBI)

November 13, 2025 8:00 AM

Curiteva, Inc. a privately held manufacturing and technology company, proudly announces the publication of a peer-reviewed study, "Novel PEEK fabrication using fused strand deposition reduces inflammation and enhances MSC differentiation promoting bone growth and implant osseointegration," in the Journal of Biomaterials (JBI). JBI is one of the most highly regarded and highest-impact journals in the biomaterials and materials science fields.Dr....

Read more

Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

November 13, 2025 7:30 AM

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce that it has received full regulatory and ethical approvals in the United Kingdom to expand its ongoing Phase 2 clinical study (SKNJCT-003) evaluating Doxorubicin Microneedle Array (D-MNA) to non-invasively treat basal...

Read more

Duane Boise and MMJ International Holdings Send Urgent Relief to Jamaica Following Category 5 Hurricane Melissa

November 12, 2025 10:45 PM

In the devastating wake of Hurricane Melissa, a powerful Category 5 storm that struck Jamaica with catastrophic winds and flooding, Duane Boise, CEO of MMJ International Holdings and former CEO of EMED Jamaica, has stepped forward once again to deliver critical humanitarian aid to the island he calls his "second home." Duane Boise, who has a long history of service to the Jamaican people through medical and emergency relief initiatives, is...

Read more

Electronic Caregiver's Addison Care(R): As OpenAI Considers Consumer Health Devices, the Future Is Already Here

November 12, 2025 5:45 PM

Following reports that OpenAI is exploring the launch of consumer health devices and monitoring tools, Electronic Caregiver, Inc. ("ECG"), developer of the Addison Care® virtual caregiver and TeleCare ecosystem, confirms that the future these AI giants are racing toward has already been built and is in market today."OpenAI's reported move validates exactly what we've spent fifteen years building," said Anthony Dohrmann, CEO of Electronic...

Read more

NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close

November 12, 2025 5:01 PM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced the closing of its previously announced securities purchase agreement with a single healthcare institutional investor for the purchase and sale of 3,571,429 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.68 per share in a registered direct offering (the "Offering"). The gross proceeds from the Offering are approximately $6...

Read more

DaVita Launches 'Caring Across Communities' to Support California Nonprofits

November 12, 2025 3:30 PM

DaVitaOn Nov. 13, DaVita launches its Caring Across Communities initiative, a weeklong service event dedicated to strengthening local communities across California. Through Nov. 19, nearly 1,000 DaVita teammates (employees), along with their families and loved ones, will volunteer at 30 nonprofit projects, demonstrating the company's commitment to being a "community first and a company second."The initiative is designed to support essential...

Read more

Federal HEMP Crackdown & Cannabis Court Rulings Confirm MMJ's Pharmaceutical Vision

November 12, 2025 1:20 PM

The era of "gas-station weed" and unregulated THC beverages is coming to a close. A sweeping federal appropriations bill to reopen the federal government now moving through Congress-paired with enforcement actions nationwide-will redefine hemp, re-criminalize synthetic cannabinoids, and eliminate the gray-market industry that flourished under the 2018 Farm Bill loophole.This dramatic policy shift, backed by a bipartisan coalition of 39 State...

Read more

New Book Reveals 7 Science-Backed Strategies to Retrain Your Anxious Brain, Not Just Quiet It

November 12, 2025 1:00 PM

Integrative Psychiatrist and Best-selling Author Dr. Rozina Lakhani shares a practical, science-backed approach to rewiring the brain for calm, one habit at a time.Anxiety affects nearly one in three adults, yet most advice still focuses on surface-level fixes like "just breathe" or "think positive." When stress hormones remain on overdrive, the brain literally learns to be anxious - meaning you can't simply "relax" your way out of it.In her...

Read more

iTolerance CEO, Anthony Japour, Receives BioFlorida's Research & Developer of the Year Award

November 12, 2025 10:00 AM

iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage privately-held biotechnology company focused on the development of innovative regenerative medicines, today announced that Anthony Japour, Chief Executive Officer and President of iTolerance, received the Research & Developer of the Year Award at the recently held BioFlorida Innovation Conference in Miami, FL. "We are honored that BioFlorida has recognized our team's work and...

Read more

U.S. Hospitals Underfund AI Governance as Adoption Accelerates

November 12, 2025 9:00 AM

A new Black Book Research survey of 182 U.S. hospital leaders reveals widespread underinvestment in AI governance, safety, and compliance heading into 2026. Although artificial intelligence continues to expand across clinical and operational workflows, the median 2026 budget share for AI governance and safety is just 4.2%, and only 22% of hospitals report high confidence that they could deliver a complete, auditable AI explanation within 30 days...

Read more

Pace Surgical Receives FDA 510(k) Clearance for Ultra Compression Screw System for Foot and Ankle Reconstruction

November 12, 2025 8:10 AM

Pace Surgical, a Runway Healthcare portfolio company pioneering advancements in lower extremity fixation, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Ultra Compression Screw System™, indicated for the internal fixation and stabilization of arthrodesis, osteotomies, fractures, and nonunion of the foot and ankle.The Ultra Compression Screw System introduces a patent-pending approach to...

Read more

Donath Facial Plastic Surgery Announces Annual Open House

November 12, 2025 8:00 AM

Donath Facial Plastic Surgery has announced the return of its annual Fabulous Friday Open House, a much-anticipated community event offering patients and guests exclusive savings, giveaways, and an inside look at the practice's full range of surgical and non-surgical facial rejuvenation services. The event will take place on Friday, November 14, 2025, featuring both in-person and online participation options.The in-person open house will be held...

Read more

Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line

November 12, 2025 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing therapies targeting the epigenetic roots of cancer, aging, and age-related disease, today announced new preclinical findings showing that its lead investigational compound Telomir-1 produced a strong, dose-dependent reduction of intracellular iron in human keratinocyte (HaCaT) cells - outperforming the FDA-approved...

Read more

Wellgistics Health Launches EinsteinRx as the Premier AI Prescription Management Hub Solution to Integrate Physical and Technology Healthcare Infrastructure

November 12, 2025 7:40 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a leader in the integration of physical and technology healthcare infrastructure for prescription drugs, today announced that it has launched EinsteinRx™, the premier prescription management solution to integrate physical and technology infrastructure for the prescription drug industry. EinsteinRx allows for the fully customizable, seamless flow of information from the physician to the...

Read more

Robert A. Winn Excellence in Clinical Trials Award Program Announces 2025 Awardees for the Winn Career Development Award

November 12, 2025 7:00 AM

Originally published by The Robert A. Winn Excellence in Clinical Trials Award ProgramThe Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards) recently announced 79 new physician-researchers from across the United States have been selected to join the fifth annual cohort of the Winn Career Development Award (Winn CDA) program, a rigorous two-year curriculum designed to advance community-focused clinical research.The Winn...

Read more